A new article published in Patient Safety & Quality Healthcare examines tissue dissemination risk in laparoscopic morcellation and why this is no longer just a technical consideration in the OR. When tissue fragmentation occurs without effective containment, the implications may extend beyond a single procedure, including potential cancer upstaging, benign tissue spread, and increased institutional liability. At the same time, real-world practice remains variable: Differences

Laparoscopic morcellation used in hysterectomy and myomectomy procedures remains an important tool in minimally invasive gynecologic surgery. However, tissue fragmentation without effective containment may disseminate malignant or viable tissue within the peritoneal cavity, with potential implications for oncologic outcomes, benign disease burden, informed consent defensibility, and institutional liability exposure. In an era of heightened scrutiny around tissue disseminatio

Society of Gynecologic Oncology Newsletter In 2014, the U.S. Food and Drug Administration (FDA) issued a safety communication cautioning against uncontained laparoscopic power morcellation for hysterectomy and myomectomy due to the risk of spreading unsuspected uterine malignancy. Hospitals responded by removing powered devices from operating rooms. But in many cases, this shift simply replaced power with manual morcellation through small abdominal or vaginal incisions — ofte

July 2025 DOI: 10.13140/RG.2.2.21948.76162 Authors: Shabnam Gupta Brigham and Women's Hospital Abstract Contained tissue extraction is a...